Health
AstraZeneca trial, illness link ‘unlikely’ – Wauchope Gazette
The adverse events that led to a pause in trials evaluating AstraZeneca Plc’s COVID-19 vaccine candidate may not have been associated with the vaccine itself,…
The adverse events that led to a pause in trials evaluating AstraZeneca Plc’s COVID-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted online by the Oxford University.
Enrolment in the British drug maker’s global trials of the vaccine, which it is developing with researchers at Oxford University, was paused on September 6 after a participant in its UK trial had a serious side effect thought to be a…
-
Noosa News15 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General19 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia
-
General8 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Business24 hours agoTop brokers name 3 ASX shares to buy next week 5 October 2025